[Toxic polyneuropathies].
D000818:Animals; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000893:Anti-Inflammatory Agents / Q000009:adverse effects; D000927:Anticonvulsants / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects; D001342:Autonomic Nervous System Diseases / Q000139:chemically induced; D002317:Cardiovascular Agents / Q000009:adverse effects; D003389:Cranial Nerve Diseases / Q000139:chemically induced; D004785:Environmental Pollutants / Q000009:adverse effects; D006801:Humans; D009410:Nerve Degeneration / Q000187:drug effects; D009422:Nervous System Diseases / Q000139:chemically induced; D009468:Neuromuscular Diseases / Q000139:chemically induced; D010525:Peripheral Nerves / Q000187:drug effects; D011115:Polyneuropathies / Q000139:chemically induced*; D011619:Psychotropic Drugs / Q000009:adverse effects; D012306:Risk; D012677:Sensation / Q000187:drug effects
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D000927:Anticonvulsants; D000970:Antineoplastic Agents; D002317:Cardiovascular Agents; D004785:Environmental Pollutants; D011619:Psychotropic Drugs
Toxische Polyneuropathien.